Jackson Creek Investment Advisors LLC Adma Biologics, Inc. Transaction History

Jackson Creek Investment Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$15.44 - $20.61 $910 - $1,215	-59 Reduced 0.07%	88,272 $1.75 Million
Q4 2024 Feb 06, 2025	SELL	$15.62 - $22.62 $42,783 - $61,956	-2,739 Reduced 3.01%	88,331 $1.52 Million
Q3 2024 Nov 04, 2024	SELL	$11.21 - $20.03 $333,071 - $595,131	-29,712 Reduced 24.6%	91,070 $1.82 Million
Q2 2024 Aug 01, 2024	SELL	$5.98 - $11.18 $473,185 - $884,651	-79,128 Reduced 39.58%	120,782 $1.35 Million
Q1 2024 May 09, 2024	BUY	$4.4 - $6.74 $879,604 - $1.35 Million	199,910 New	199,910 $1.32 Million

401

205M

3.06M

1.88M

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.06B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.